Candel Therapeutics Stock Soars After Cantor Fitzgerald’s Overweight Rating

All NewsApril 20, 2026

Candel Therapeutics ripped higher on Monday after a bullish analyst initiation, underscoring how narrative can outpace fundamentals.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Candel Therapeutics Stock Soars After Cantor Fitzgerald’s Overweight Rating

The UCW Newswire : Financial, Business and Tech News

Recent Headlines

Wells Fargo sends surprising message to RV buyers about Camping World

Another holiday airline cancels all flights, eyes bankruptcy

Amazon’s $188 storage shed features a built-in pergola

AMD stock jumps 13% after 5-star analyst resets price target

Higher-than-expected October inflation sparks Treasury sell-off